Compare Abeona Therapeutics Inc (ABEO) vs BHP Billiton Limited (BHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs BHP Billiton Limited — how do they compare? Abeona Therapeutics Inc trades at $7.46 (market cap $421.19M), while BHP Billiton Limited trades at $90.59 (market cap $229.15B). The key difference: BHP Billiton Limited is far larger — about 544.1× Abeona Therapeutics Inc's market cap, and BHP Billiton Limited pays a 2.95% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | BHP | |
|---|---|---|
Market Cap | $421.19M | $229.15B |
Sector | Health | Basic Materials |
52-Week High | $7.45 | $93.15 |
52-Week Low | $4.17 | $52.14 |
Enterprise Value | $276.10M | $243.35B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
BHP trades at $90.61, up 0.22% with a bullish technical signal supported by moving averages. The company reported mixed Q4 2025 earnings, missing EPS estimates but maintaining strong profitability with 18.97% net margins. Recent operational challenges include strikes at Port Hedland iron ore operations, while copper production declines in Chile. Valuation metrics show a P/E of 22.36 and P/B of 4.54, reflecting premium pricing relative to historical levels.
The outlook remains cautiously optimistic with analyst consensus leaning hold (64.52%) amid labor disputes and production volatility. Key opportunities include exposure to AI-driven copper demand growth, while risks center on strike impacts and fluctuating commodity prices. The stock's current technical strength faces fundamental headwinds from operational disruptions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About BHP Billiton Limited
BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →
